Acetylsalicylic Acid and COVID-19 Prevention: A Comment.
作者信息
Sookaromdee Pathum, Wiwanitkit Viroj
机构信息
Private Academic Consultant Center, Bangkok, Thailand.
Dr DY Patil University, Pune, India.
出版信息
Clin Appl Thromb Hemost. 2021 Jan-Dec;27:10760296211027660. doi: 10.1177/10760296211027660.
Abstract
摘要
相似文献
1
Acetylsalicylic Acid and COVID-19 Prevention: A Comment.乙酰水杨酸与新冠病毒预防：一则评论
Clin Appl Thromb Hemost. 2021 Jan-Dec;27:10760296211027660. doi: 10.1177/10760296211027660.
2
Acetylsalicylic acid (Aspirin): a potent medicine for preventing COVID-19 deaths caused by thrombosis and pulmonary embolism.乙酰水杨酸（阿司匹林）：一种预防由血栓形成和肺栓塞导致的新冠死亡的有效药物。
Eur Rev Med Pharmacol Sci. 2020 Sep;24(18):9244-9245. doi: 10.26355/eurrev_202009_23005.
3
Is Aspirin the True Protective Therapy in Coronavirus Disease 2019 Patients?阿司匹林是2019冠状病毒病患者真正的保护性治疗方法吗？
Anesth Analg. 2021 Sep 1;133(3):e41. doi: 10.1213/ANE.0000000000005635.
4
Enhanced platelet inhibition treatment improves hypoxemia in patients with severe Covid-19 and hypercoagulability. A case control, proof of concept study.强化血小板抑制治疗可改善严重 COVID-19 合并高凝状态患者的低氧血症：一项病例对照、概念验证研究。
Pharmacol Res. 2020 Aug;158:104950. doi: 10.1016/j.phrs.2020.104950. Epub 2020 May 23.
5
Is Acetylsalicylic Acid a Safe and Potentially Useful Choice for Adult Patients with COVID-19 ?乙酰水杨酸（阿司匹林）对于 COVID-19 成年患者来说是否安全且可能有效？
Drugs. 2020 Sep;80(14):1383-1396. doi: 10.1007/s40265-020-01365-1.
6
IL-1 induces throboxane-A2 (TxA2) in COVID-19 causing inflammation and micro-thrombi: inhibitory effect of the IL-1 receptor antagonist (IL-1Ra).白细胞介素-1（IL-1）在 COVID-19 中诱导血栓烷 A2（TxA2）的产生，导致炎症和微血栓形成：白细胞介素-1 受体拮抗剂（IL-1Ra）的抑制作用。
J Biol Regul Homeost Agents. 2020;34(5):1623-1627. doi: 10.23812/20-34-4EDIT-65.
7
Reduced blood platelet sensitivity to aspirin in coronary artery disease: are dyslipidaemia and inflammatory states possible factors predisposing to sub-optimal platelet response to aspirin?冠状动脉疾病中血小板对阿司匹林的敏感性降低：血脂异常和炎症状态是否可能是导致血小板对阿司匹林反应欠佳的易感因素？
Basic Clin Pharmacol Toxicol. 2006 May;98(5):503-9. doi: 10.1111/j.1742-7843.2006.pto_343.x.
8
Comment on "Pre-hospital antiplatelet medication use on COVID-19 disease severity".关于“院前使用抗血小板药物对新冠病毒疾病严重程度的影响”的评论
Heart Lung. 2022 Sep-Oct;55:164-165. doi: 10.1016/j.hrtlng.2022.04.020. Epub 2022 May 2.
9
Can other coronavirus infections cause a cryptogenic stroke in a young patient?其他冠状病毒感染会导致年轻患者隐源性卒中吗？
BMJ Case Rep. 2021 Mar 3;14(3):e239113. doi: 10.1136/bcr-2020-239113.
10
Aspirin and platelets: the antiplatelet action of aspirin and its role in thrombosis treatment and prophylaxis.阿司匹林与血小板：阿司匹林的抗血小板作用及其在血栓形成治疗和预防中的作用。
Semin Thromb Hemost. 1997;23(4):349-56. doi: 10.1055/s-2007-996108.
本文引用的文献
1
Could Low Doses Acetylsalicylic Acid Prevent Thrombotic Complications in COVID-19 Patients?低剂量乙酰水杨酸能否预防 COVID-19 患者的血栓并发症？
Clin Appl Thromb Hemost. 2021 Jan-Dec;27:10760296211014592. doi: 10.1177/10760296211014592.
2
Mechanism of thrombocytopenia in COVID-19 patients.新型冠状病毒肺炎患者血小板减少的机制。
Ann Hematol. 2020 Jun;99(6):1205-1208. doi: 10.1007/s00277-020-04019-0. Epub 2020 Apr 15.
3
Hemorrhagic Problem Among the Patients With COVID-19: Clinical Summary of 41 Thai Infected Patients.新型冠状病毒肺炎患者的出血问题：41例泰国感染患者的临床总结
Clin Appl Thromb Hemost. 2020 Jan-Dec;26:1076029620918308. doi: 10.1177/1076029620918308.
Zotero 插件